United States · Series B startup

Who invested in Capstan Therapeutics

One round we have observed, with the 16 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$175Mraised across 1 round since 2024, from 2 sources

Latest round: Series B, $175MMar 2024
Investors: 16

See who backed them

The rounds

Mar 2024
Series B$175M
Reported by Firms' own news pages and 1 otherSEC filing: $63M sold, first sale Nov 2021

Founders and team

From the SEC filings it signed: 5 on the team.

Adrian BotExecutive Officeri
Justin ThackerExecutive Officeri
Laura ShawverExecutive Officer, Directori
Priya KarmaliExecutive Officeri
Ramin Farzaneh-FarExecutive Officeri

On the board, as filediAthena CountouriotisErez ChimovitsFabio PucciKaren SmithMichael BaranMichal SilverbergNandita ShangariNanna LuneborgRajul Jain

Everyone who backed them

Polaris PartnersVC firm1round

OrbiMedPrivate equity1round

RA Capital ManagementPrivate equity1round

Perceptive AdvisorsAsset manager1round

Sofinnova InvestmentsVC firm1round

Novartis Venture FundCorporate VC1round

Eli LillyCorporate VC1round

Forbion Capital PartnersPrivate equity1round

Alexandria Real Estate EquitiesVC firm1round

MubadalaPrivate equity1round

PfizerCorporate VC1round

Johnson & Johnson Robotics and Digital SolutionsCorporate VC1round

Bristol Myers SquibbVC firm1round

Vida VenturesVC firm1round

Leaps by BayerCorporate VC1round

Finchley Healthcare Ventures IncGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Capstan Therapeutics

Who invested in Capstan Therapeutics?

Capstan Therapeutics's investors include Polaris Partners, OrbiMed, RA Capital Management, Perceptive Advisors and Sofinnova Investments, and 11 more on record.